DK370576A - Fremgangsmade til fremstilling af prostaglandinanaloge - Google Patents

Fremgangsmade til fremstilling af prostaglandinanaloge

Info

Publication number
DK370576A
DK370576A DK370576A DK370576A DK370576A DK 370576 A DK370576 A DK 370576A DK 370576 A DK370576 A DK 370576A DK 370576 A DK370576 A DK 370576A DK 370576 A DK370576 A DK 370576A
Authority
DK
Denmark
Prior art keywords
innalogue
prostagland
procedure
prostagland innalogue
innalogue procedure
Prior art date
Application number
DK370576A
Other languages
English (en)
Inventor
M Hayashi
S Kori
H Miyake
T Okada
Original Assignee
Ono Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB34688/75A external-priority patent/GB1521747A/en
Application filed by Ono Pharmaceutical Co filed Critical Ono Pharmaceutical Co
Publication of DK370576A publication Critical patent/DK370576A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0016Analogues having the carboxyl group in the side-chains replaced by other functional groups containing only hydroxy, etherified or esterified hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0025Analogues having the carboxyl group in the side-chains replaced by other functional groups containing keto groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0033Analogues having the carboxyl group in the side-chains replaced by other functional groups containing sulfur
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006Esters of acyclic acids which can have further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK370576A 1975-08-20 1976-08-17 Fremgangsmade til fremstilling af prostaglandinanaloge DK370576A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB34688/75A GB1521747A (en) 1975-08-20 1975-08-20 Prostaglandin analogues
GB4346475 1975-10-22

Publications (1)

Publication Number Publication Date
DK370576A true DK370576A (da) 1977-02-21

Family

ID=26262398

Family Applications (2)

Application Number Title Priority Date Filing Date
DK370576A DK370576A (da) 1975-08-20 1976-08-17 Fremgangsmade til fremstilling af prostaglandinanaloge
DK494289A DK494289D0 (da) 1975-08-20 1989-10-06 Analogifremgangsmaade til fremstilling af terapeutisk anvendelige prostaglandianaloge

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK494289A DK494289D0 (da) 1975-08-20 1989-10-06 Analogifremgangsmaade til fremstilling af terapeutisk anvendelige prostaglandianaloge

Country Status (12)

Country Link
US (1) US4065632A (da)
JP (1) JPS5825669B2 (da)
AU (1) AU501896B2 (da)
CA (1) CA1091663A (da)
CH (1) CH613950A5 (da)
DE (1) DE2637393C2 (da)
DK (2) DK370576A (da)
FR (1) FR2321277A1 (da)
HK (1) HK7081A (da)
IE (1) IE44161B1 (da)
LU (1) LU75622A1 (da)
NL (1) NL7609134A (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4092349A (en) * 1976-11-10 1978-05-30 Pfizer Inc. 11-Desoxy-15-thiaprostaglandins
US4148804A (en) * 1978-01-11 1979-04-10 Pfizer Inc. 2-Descarboxy-2-(tetrazol-5-yl) 11-desoxy-15-thiaprostaglandins

Also Published As

Publication number Publication date
CA1091663A (en) 1980-12-16
LU75622A1 (da) 1977-04-21
DE2637393A1 (de) 1977-02-24
IE44161L (en) 1977-02-20
HK7081A (en) 1981-03-13
DK494289A (da) 1989-10-06
AU501896B2 (en) 1979-07-05
US4065632A (en) 1977-12-27
AU1691376A (en) 1978-02-23
JPS5225745A (en) 1977-02-25
DE2637393C2 (de) 1984-03-29
DK494289D0 (da) 1989-10-06
FR2321277B1 (da) 1981-03-20
NL7609134A (nl) 1977-02-22
FR2321277A1 (fr) 1977-03-18
IE44161B1 (en) 1981-08-26
CH613950A5 (da) 1979-10-31
JPS5825669B2 (ja) 1983-05-28

Similar Documents

Publication Publication Date Title
DK143706C (da) Fremgangsmaade til fremstilling af svovlholdige organosiliciumforbindelser
DK49676A (da) Fremgangsmade til fremstilling af hypolipidemiske midler
DK193876A (da) Fremgangsmade til fremstilling af polypeptid
DK355676A (da) Fremgangsmade til bekempelse af insekter
DK426476A (da) Fremgangsmade til rensning af halogensilaner
DK484576A (da) Fremgangsmade til fremstilling af 2-aroyl-3-phenyl-benzothiophenforbindelser
DK87876A (da) Fremgangsmade til fremstilling af n-acyl-l-metionin
DK243176A (da) Fremgangsmade til fremstilling af polycliske forbindelser
DK107876A (da) Fremgangsmade til fremstilling af thiocarbamider
DK324776A (da) Fremgangsmade til fremstilling af 3-cyanoimino-3-aminopropionitriler
DK145877A (da) Fremgangsmade til immoblisering af glucoseisomerase
DK318876A (da) Fremgangsmade til fremstilling af prostaglandinanaloge
DK357576A (da) Fremgangsmade til fremstilling af indoler
DK305876A (da) Fremgangsmade til fremstilling af l-pyroglutamyl-l-prolinamid
DK283476A (da) Fremgangsmade til fremstilling af beta-acylpyrroler
DK435876A (da) Fremgangsmade til fremstilling af phosphitchlorider
DK435776A (da) Fremgangsmade til fremstilling af phosphitchlorider
DK134176A (da) Fremgangsmade til fremstilling af alkylestere af hemicaronaldehyd
DK174676A (da) Fremgangsmade til fremstilling af phosphornitrider
DK370576A (da) Fremgangsmade til fremstilling af prostaglandinanaloge
DK343576A (da) Fremgangsmade til fremstilling af styrylamidiner
DK62676A (da) Fremgangsmade til fremstilling af indoler
DK477076A (da) Fremgangsmade til fremstilling af betadihydrothebain
DK219976A (da) Fremgangsmade til fremstilling af prostaglandinanaloge
DK299376A (da) Fremgangsmade til fremstilling af thioglycoler

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment